Pancreatic Cancer Research

ResearcherUniversitat Autònoma de BarcelonaActive in the last 2 years

José A. Pumarega

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6950-6702; OpenAlex author ID A5034495677. Sources: OpenAlex.

Their work

Papers
10 (first author 7, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2012: 2 papers · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 3 papers · 2020: 1 paper · 2021: none · 2022: 2 papers · 2023: none · 2024: none · 2025: 1 paper

Papers 10

  1. Factors influencing the diagnostic basis in pancreatic cancer. A study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. First author DOI 10.1016/j.ctarc.2025.101009↗
  2. Timing of Toenail Collection and Concentrations of Metals in Pancreatic Cancer. Evidence Against Disease Progression Bias. Co-author DOI 10.1007/s12403-021-00436-2↗
  3. Plasma concentrations of persistent organic pollutants and pancreatic cancer risk. Co-author DOI 10.1093/ije/dyab115↗
  4. Influence of KRAS mutations, persistent organic pollutants, and trace elements on survival from pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.envres.2020.109781↗
  5. Concentrations of trace elements and KRAS mutations in pancreatic ductal adenocarcinoma. First author DOI 10.1002/em.22296↗
  6. Toenail concentrations of trace elements and occupational history in pancreatic cancer. First author DOI 10.1016/j.envint.2019.03.037↗
  7. Methodological issues in a prospective study on plasma concentrations of persistent organic pollutants and pancreatic cancer risk within the EPIC cohort. First author DOI 10.1016/j.envres.2018.11.027↗
  8. Adjusting serum concentrations of organochlorine compounds by lipids and symptoms: a causal framework for the association with K-ras mutations in pancreatic ca… First author DOI 10.1016/j.chemosphere.2014.04.066↗
  9. Pancreatic cancer risk and levels of trace elements. Co-author DOI 10.1136/gutjnl-2011-301086↗
  10. Relationships of hepatic and pancreatic biomarkers with the cholestatic syndrome and tumor stage in pancreatic cancer. First author DOI 10.3109/1354750x.2012.701331↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Miquel S. Porta · 8 shared papers, 2012–2025 · strength 0.73
  2. Magda Gasull · 5 shared papers, 2019–2025 · strength 0.62
  3. Judit Camargo · 3 shared papers, 2019–2022 · strength 0.34
  4. André F.S. Amaral · 4 shared papers, 2012–2020 · strength 0.33
  5. Paolo Vineis · 1 shared paper, 2025 · strength 0.18
  6. María‐Dolores Chirlaque · 1 shared paper, 2025 · strength 0.18
  7. Verena Andrea Katzke · 1 shared paper, 2025 · strength 0.18
  8. Sandra Milena Colorado-Yohar · 1 shared paper, 2025 · strength 0.18
  9. Marta Crous‐Bou · 1 shared paper, 2025 · strength 0.18
  10. Pietro Ferrari · 1 shared paper, 2025 · strength 0.18
  11. Núria Malats · 3 shared papers, 2012–2019 · strength 0.16
  12. Yu Chen · 1 shared paper, 2022 · strength 0.14
  13. Esteve Fernández · 1 shared paper, 2022 · strength 0.14
  14. Álvaro Gómez‐Tomás · 1 shared paper, 2019 · strength 0.10
  15. Lawrence S. Engel · 1 shared paper, 2020 · strength 0.10
  16. Jeanine M. Genkinger · 1 shared paper, 2020 · strength 0.10
  17. Tomás López‐Jiménez · 2 shared papers, 2012–2014 · strength 0.07
  18. Francisco X. Real · 2 shared papers, 2012 · strength 0.06
  19. Debra T. Silverman · 1 shared paper, 2012 · strength 0.03
  20. Roger Laughlin Milne · 1 shared paper, 2012 · strength 0.03
  21. Alfredo Carrato · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.